The Hong Kong Polytechnic University
Hong Kong
Location status: Recruiting
NCT Number: NCT06769672
The purpose of this study is to evaluate tDCS combined with cognitive-motor training on dual-task interference during dual-task walking, dual-task foot pedaling and the corresponding alterations of brain activity.
Interested in participating?
Request Info50 year and older
All sexes
Interventional
Not applicable
Hong Kong
Location status: Recruiting
In China, the prevalence of stroke increased by 106.0% (93.7-118.8) between 1990 and 2019, highlighting the persistent and substantial burden of this condition. Post-stroke recovery, particularly the ability to achieve community ambulation, plays a critical role in improving health-related quality of life. Effective community ambulation in daily life requires the ability to dual-task-namely, to perform concurrent tasks requiring attentional resources while maintaining walking function and balance. Emerging evidence suggests that stroke survivors face greater challenges in walking function and dual-task balance compared to their age-matched, able-bodied counterparts. For instance, when tasked with recalling a shopping list while walking, stroke patients exhibit a more pronounced decline in both walking speed and cognitive performance relative to control groups. Given the necessity for stroke survivors to reintegrate into the community, it is imperative to thoroughly investigate this phenomenon of cognitive-motor interference.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
participants receive three 20-minute active tDCS treatment and three 60-minute COGMOTION dual-task exercise sessions per week for four consecutive weeks.
participants receive three 20-minute sham tDCS treatment and three 60-minute COGMOTION dual-task exercise sessions per week for four consecutive weeks.
Time frame: Through study completion, an average of 1 year
Gait speed under dual-task condition will be recorded
Time frame: Through study completion, an average of 1 year
Number of correct responses will be measured during dual-task conditions
Time frame: Through study completion, an average of 1 year
Oxyhemoglobin concentration changes will be measured using functional near infra-red spectroscopy during dual-task walking
Time frame: Through study completion, an average of 1 year
Gait cadence will be measured during dual-task walking
Time frame: Through study completion, an average of 1 year
Gait cycle duration will be measured during dual-task walking
Time frame: Through study completion, an average of 1 year
Stride length will be measured during dual-task walking
Time frame: Through study completion, an average of 1 year
Correct reaction time under dual-task walking will be recorded
Time frame: Through study completion, an average of 1 year
Blood oxygenation level changes will be measured using Magnetic Resonance Imaging during dual-task foot pedaling
Time frame: Through study completion, an average of 1 year
cadence under dual-task foot pedaling will be recorded
Time frame: Through study completion, an average of 1 year
Number of correct responses under dual-task foot pedaling will be recorded
Time frame: Through study completion, an average of 1 year
Step time under dual-task walking will be recorded
Time frame: Through study completion, an average of 1 year
Peak angular (dorsi-plantar flexion) velocity under dual-task foot pedaling will be recorded
Time frame: Through study completion, an average of 1 year
Correct reaction time under dual-task foot pedaling will be recorded
Time frame: Through study completion, an average of 1 year
10-meter walking test will be used to assess single-task walking speed in meters per second
Time frame: Through study completion, an average of 1 year
Mini Balance Evaluation Systems Test will be used to assess postural control, with total points from 0-28. Higher points indicate better performance.
Time frame: Through study completion, an average of 1 year
Activities-specific Balance Confidence Scale will be used to assess confidence of functional balance performance, with total points from 0-100. Higher points indicate better performance.
Time frame: Through study completion, an average of 1 year
Stroop color word test will be used to assess executive function
Time frame: before the initiation of training
Montreal Cognitive Assessment will be used to assess global cognition, with total points from 0-30. Higher points indicate better performance.
Time frame: Through study completion, an average of 1 year
Trail Making Test will be used to assess executive function
Time frame: Through study completion, an average of 1 year
Monthly telephone interviews for recording fall incidence
Time frame: Through study completion, an average of 1 year
Walking time under dual-task walking at maximal speed will be recorded
Time frame: Through study completion, an average of 1 year
Accuracy under dual-task walking at maximal speed will be recorded
Contact information is provided by the study sponsor or research team.
The Hong Kong Polytechnic University
Other
The Effect of Dual-task Training Combined With tDCS on Cognitive-motor Interference and Related Brain Activity in Stroke Patients
Acronym: dual-task tDCS
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03627364
Brain Diseases, Cardiovascular Diseases
Recife, Pernambuco, Brazil
View Trial DetailsNCT05378035
Arrhythmias, Cardiac, Arterial Thromboembolism
Hong Kong
View Trial DetailsNCT03821129
Brain Diseases, Cardiovascular Abnormalities
Tucson, Arizona, United States
View Trial DetailsNCT06615973
Brain Disease, Brain Diseases
Bethesda, Maryland, United States
View Trial Details